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Background: Abnormal sex chromosome numbers in humans are observed in Turner (45,X) and Klinefelter (47,XXY)
syndromes. Both syndromes are associated with several clinical phenotypes, whose molecular mechanisms are
obscure, and show a range of inter-individual penetrance. In order to understand the effect of abnormal numbers
of X chromosome on the methylome and its correlation to the variable clinical phenotype, we performed a
genome-wide methylation analysis using MeDIP and Illumina’s Infinium assay on individuals with four karyotypes:
45,X, 46,XY, 46,XX, and 47,XXY.
Results: DNA methylation changes were widespread on all autosomal chromosomes in 45,X and in 47,XXY
individuals, with Turner individuals presenting five times more affected loci. Differentially methylated CpGs, in
most cases, have intermediate methylation levels and tend to occur outside CpG islands, especially in individuals with
Turner syndrome. The X inactivation process appears to be less effective in Klinefelter syndrome as methylation on the
X was decreased compared to normal female samples. In a large number of individuals, we verified several loci by
pyrosequencing and observed only weak inter-loci correlations between the verified regions. This suggests a certain
stochastic/random contribution to the methylation changes at each locus. Interestingly, methylation patterns on some
PAR2 loci differ between male and Turner syndrome individuals and between female and Klinefelter syndrome
individuals, which possibly contributed to this distinguished and unique autosomal methylation patterns in Turner and
Klinefelter syndrome individuals.
Conclusions: The presented data clearly show that gain or loss of an X chromosome results in different epigenetic
effects, which are not necessary opposite.
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In mammals, the X chromosome has very unique char-
acteristics: the presence of two X chromosomes in fe-
males and only one in males requires the existence of a
dosage compensation mechanism(s) to ensure “nearly”
equal genetic contributions in both sexes [1]. However,
gene expression levels on the X chromosome still differ
between males and females; this is due to unequal X* Correspondence: osman.elmaarri@ukb.uni-bonn.de
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creativecommons.org/publicdomain/zero/1.0/inactivation across the X chromosome. Some genes escape
the inactivation process [2], while other regions—specifi-
cally those with homology on the Y chromosome (termed
pseudo autosomal regions)—are not inactivated (like on
autosomes) in either 46,XY or 46,XX [3]. Therefore, an ab-
normal number of X chromosomes—loss of an X chromo-
some in females (Turner syndrome) or gain of an extra
chromosome in males (Klinefelter syndrome)—can lead to
profound imbalances in gene dosage on the X chromo-
some and thus to non-standard phenotypes in humans [4].
Sex chromosome abnormalities have a high prevalence
in humans, with Klinefelter syndrome (47,XXY) beingrticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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(45,X) most common in women (1/2500) [5]. Such
chromosomal abnormalities lead to a high risk of miscar-
riage and stillbirth. However, if an individual with Turner
syndrome survives birth, they possess characteristic fea-
tures, such as short stature, webbed neck and ovarian dys-
function, leading to infertility, osteoporosis, cardiovascular
malformations, diabetes mellitus, and thyroid auto-
immune diseases [6]. Klinefelter syndrome, on the other
hand, apart from phenotypic features, such as high stature,
gynecomastia, and infertility, is often linked to declined
verbal skills [7]. Both syndromes have the hallmark char-
acteristic of abnormal endocrine balance and display
hypergonadotropic hypogonadism [8–10]. The details of
the underlying molecular mechanisms that lead to the de-
velopment of these symptoms associated with X chromo-
some abnormalities are poorly understood. In particular,
molecular insights on epigenetic changes responsible for
the occurrence of these phenotypes are missing.
Molecular studies to gain knowledge on the changes in
epigenetics and gene expressions associated with abnor-
mal numbers of chromosomes could improve the under-
standing of the molecular basis of these symptoms. To
date, no systematic detailed studies on expression as well
as epigenetic changes that combine both the gain (as in
47,XXY) and the loss (as in 45,X) of the X chromosome
have been published. However, this issue is partially
addressed by several papers that analyzed limited number
of samples from a single available tissue. For instance,
Klinefelter syndrome, a combined genome-wide expres-
sion and DNA methylation in one schizophrenic brain
sample, was reported [11], as well as genome-wide expres-
sion analysis from testis tissue [12] or whole blood
[13, 14]. Several other studies analyzed single loci in order
to develop a molecular diagnosis method for detection
[15, 16]. Regarding Turner syndrome, here, too, only few
studies exist which performed genome-wide expression
analysis, i.e., in fibroblast [17] and in cell free DNA de-
rived form amniotic fluid [18]. In other studies, single loci
were analyzed mainly for diagnostic purposes [19].
The relationship between the number of X chromo-
somes and clinical phenotypes can better be revealed
when samples of gains as well as losses of an X chromo-
some are studied simultaneously under the same experi-
mental conditions. For this reason, we studied the DNA
methylation status of CpG islands and promoters in
blood samples derived from Turner (45,X: a loss of one
X) and Klinefelter (47,XXY: gain of one X) syndrome in-
dividuals and compared them to healthy males (46,XY)
and females (46,XX).
Our results show that loss of an X chromosome has
much more profound consequences than gain of an
additional X chromosome. About five times more loci
(considering only autosomal CpG sites) are affected inTurner than in Klinefelter individuals. Moreover, about
80 % of the changes in Turner individuals are hypo-
methylated, while nearly equal numbers of hypo- and
hypermethylated CpG sites were observed in Klinefelter
individuals. Affected loci, especially in Turner individ-
uals, are characterized by intermediate methylation
level in 46,XY males/46,XX females and are typically lo-
cated outside of CpG islands. Methylation on the in-
active X in Klinefelter samples appears to be less than
what is observed in normal female samples, indicating a
non-optimal inactivation process in Klinefelter individ-
uals. Gene ontology analysis reveals clusters of genes,
which are expected to be involved in the clinical pheno-
type. In Turner individuals, these were immune re-
sponse, immune system processes, and meiosis, while
in Klinefelter individuals, these included cellular pro-
cesses involved in reproduction. We also highlight the
association between haploinsufficient conditions and
extent of the methylation state at pseudoautosomal re-
gions (mainly PAR2) in X chromosomal aberrations.
Results
Illumina 27K genome-wide DNA methylation profiling
reveals extensive methylation changes in both Turner
and Klinefelter samples across the whole genome
Our pilot study (performed on Illumina 27K methylation
arrays) showed considerable differences in methylation be-
tween Turner and Klinefelter individuals on the one hand
and males and females on the other hand. When consider-
ing only the autosomal loci, a clear distinction of all four
groups can be seen as Euclidean-based hierarchical cluster-
ing, while PCA analysis shows Turner samples to be the
most distant from other samples (Fig. 1). The volcano plot
in Fig. 2 illustrates the number of affected CpGs and the
magnitude of differences. Turner samples harbored nearly
five times more changes than Klinefelter samples. For this
analysis, we define differential methylation as the differ-
ences of more than 10 % methylation (calculated as the
difference between beta value transformed average M
values—see Methods) and a false discovery rate of <5 %.
On autosomes, 815 (676 hypo- and 139 hypermethylated
in Turner samples) and 174 (90 hypo- and 84 hypermethy-
lated in Klinefelter samples) different CpG sites are differ-
entially methylated when comparing male to Turner and
to Klinefelter samples, respectively. When comparing fe-
male to Turner and Klinefelter samples, 592 (470
hypo- and 122 hypermethylated in Turner samples)
and 88 (40 hypo- and 48 hypermethylated in Klinefelter
samples) CpGs are differentially methylated, respectively
(for detailed list of affected genes see Additional file 1).
On the X chromosome, a large number of differences
were observed when a sample with one X was compared
to another sample of two X, as in the comparison of
Turner samples to female samples and male samples to
Fig. 1 Hierarchical clustering and principal component analysis
(PCA) of the Illumina 27K data. The figure is based only on
autosomal loci. a Supervised analysis testing for differences between
groups using ANOVA and applying a cutoff of <5 % false discovery
rate (FDR), corresponding to a p value of 3.11E-4 and 148 CpG sites;
b Unsupervised hierarchical clustering on the normalized data
without applying a statistical hypothesis. The heat maps in the
upper part of the figure correspond to one sample for each column
and one locus for each horizontal line; red to green corresponds to
relatively hypermethylated (red) to hypomethylated (green). In the
lower part of the figure, each of the spheres corresponds to one
sample and the connecting lines correspond to the two nearest
neighbors (more similar) of a particular sample
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between Turner samples and male samples and between
Klinefelter samples and female samples. This indicates
that in Turner and Klinefelter individuals, X chromosome
activity depends on the number of X chromosomes. This
in turn suggests that the X chromosome in Turner in-
dividuals is as active as it is in males and that the sec-
ond X in Klinefelter individuals is as inactivated as it is
in females. Moreover, the differentially methylated re-
gions in Turner individuals (on autosomes) have four
to five times higher tendencies to be losing rather than
gaining methylation.Characteristics of the differentially methylated regions
Methylation levels of affected CpGs
The differentially methylated regions between each Turner
and Klinefelter sample and each male and female sample
were divided into eight groups as defined by the volcano
plots in Fig. 2 (i.e., four comparisons resulting in
hypo- (red, left side of the volcano plot) as well as
hypermethylation (green, right side of the volcano
plot)). Next, we studied the distribution of the methy-
lation values at the affected CpGs of each of the eight
groups in the male and female samples. The first ob-
vious observations were that most of the affected loci
have a medium level of methylation values. This was
more pronounced in affected loci in Turner samples
(Fig. 3a). Moreover, in Turner samples, the distribution of
beta values of the hypermethylated sites (Av. = 46.1 %) and
the hypomethylated sites (Av. = 52.3 %) are nearly overlap-
ping and are approximately normally distributed with
peaks at 40–60 %. In contrast, in Klinefelter samples
(Fig. 3a), the two curves corresponding to hypo-
(Av. = 55 %) and hypermethylations (Av. = 37.9 %) have
shifted to the right and left, respectively. The latter sug-
gests that in Klinefelter samples, the hypomethylated
loci are relatively good methylated in male and female
samples (i.e., >50 %) and that the hypermethylated loci
tend to be relatively less methylated in male and female
samples (i.e., <50 %). A chi-square trend test revealed
significant differences of the beta value distribution be-
tween all eight groups (on autosomes) and the total
CpGs on the array.
CpG islands status of the differentially methylated CpGs
In order to further understand the characteristics of the
affected CpGs, we investigated whether the affected
CpGs are located within CpG islands or not. In Turner
samples, the affected CpGs are overrepresented outside
CpG islands (Fig. 3b). This applied to the differentially
methylated CpGs in comparisons to male and female
samples. Equally, no difference in distribution was ob-
served between the loci that were hypo- and hyper-
methylated in comparison to male and female samples.
In Klinefelter samples, statistically significant differences
were only observed for loci being hypomethylated when
compared to male samples. These loci—as in Turner
samples—were enriched outside CpG islands. At the
affected CpGs in Klinefelter samples, we detected statis-
tically significant differences in the CpGi status distribu-
tion between hypo- and hypermethylated CpGs.
The differentially methylated regions are largely not
overlapping with age sensitive loci
Since we performed only two arrays hybridization per
karyotype group and because the ages of the three used
samples were not exactly the same (Turners, 13 ± 2 years;
Fig. 2 Volcano plots of the Illumina 27K data showing pairwise comparisons of Turner and Klinefelter samples to male and female samples. The
differences in beta values between the respective comparisons is on the X-axis, while the –log10 (p values) is on the Y-axis. Vertical dashed red/
green and horizontal blue lines represent the 10 % methylation differences and the 5 % false discovery rates cutoff, respectively. The differentially
methylated autosomal CpGs (>10 % differences and FDR <5 %) are represented by red and green filled circles for hypo and hyper methylated
loci respectively; their corresponding number is also shown. The verified CpGs by pyrosequencing are represented as blue triangles (1 = cg2487174,
2 = cg16848873, 3 = cg24169822, 4 = cg11418559, 5 = cg20191453, 6 = cg09697795, 7 = cg18059933, 8 = cg26306976, 9 = cg04451770, 10 = cg06812844,
11 = cg04452095; loci labels are as in Fig. 5). Cross-reactive loci, as defined by Chen Y. et al, [54] are labeled with a black “x”. The numbers in each figure
correspond to the number of individual CpG sites on autosomes that are hypomethylated (left) and hypermethylated (right); below each number
(in parenthesis) is the corresponding number of differentially methylated CpG cites on the X chromosome
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2.6), we investigated whether the differentially methyl-
ated CpGs contain age sensitive loci. We compared our
data with previous studies [20–22] that identified agesensitive CpGs mainly on the Illumina 27K. When com-
paring the four lists of differentially methylated regions
(each of Turner and Klinefelter samples to each of male
and female samples) to the lists of age sensitive CpGs,
Fig. 3 Characteristics of the differentially methylated CpGs. a The level of methylation of differentially methylated regions (red and green
curves represent the normal methylation frequency of the hypomethylated and the hypermethylated CpG sites, respectively) in comparison to
their methylation levels in male and female samples (blue curves represent the frequency of methylation distribution of all analyzed CpG sites).
The p values of the Chi-square test for trend between the methylation frequency distribution of either the hypo- or hypermethylated loci in
comparison to all CpG sites on the array are also shown (when significant), together with the average methylation. The autosomal (left column)
and X-linked loci (right column) were analyzed separately. b CpG island status: the differentially methylated regions were investigated for their
CpG island status and were divided into three groups, blue if the CpG occurs in a CpG island based on both the Illumina array annotation and
the UCSC, red if the CpG occurs in a CpG island based on only Illumina array annotation, and green if the CpG occurs in no CpG island. Next,
this data of each comparison is compared to the distribution of all CpGs in the array, and Chi-square p values are shown at the right. Also,
p values of the comparison between the hypo- and hyper-locations are shown
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little overlaps ranging from 0 to 3.4 % (Additional file 2).
From this analysis, we concluded that the slight age dif-
ference between the samples did not contribute to en-
richment of CpG sites that show a strong correlation
with age. We also concluded that the differentially meth-
ylated regions in Turner and Klinefelter samples are
generally not overlapping with age sensitive CpGs.
Overlaps in affected loci between Turner and Klinefelter
samples
We then investigated whether the same genes/loci are
affected in Turner and in Klinefelter samples. The Venn
diagram in Fig. 4a shows that some overlap exists between
the differentially methylated regions in Turner and Kline-
felter samples. When considering the intersections of all
four comparisons on autosomes, we observed only ten
genes (Additional file 3) that are affected in all compari-
sons (G1). When comparing pairwise overlaps between
Turner and male samples, Klinefelter and male samples,Turner and female samples jointly to Klinefelter and male
samples and Klinefelter and female samples (G9, G5, G10,
G3, G8, G4, G7, G2, G1), we observed 111 common
genes. However, the majority of the affected 858 loci are
non-overlapping loci (G12, G6, G13, G14, G11, and G15).
This indicates a considerable degree of specificity of the
methylation changes in Turner or Klinefelter individuals.
When considering the intersection between the differen-
tially methylated regions in Turner samples on the one
hand and male and female samples on the other hand, we
noted that a good fraction of the affected loci are common
(401 autosomal loci: G6, G2, G1, and G3), whereas in
Klinefelter samples, the overlaps of differentially methyl-
ated genes with male and female samples are relatively
few (36 autosomal loci: G11, G5, G1, and G4). This again
indicates some degree of sex specificity in the differences.
We then investigated whether the directions of changes
(i.e., hyper- or hypomethylation) are the same when com-
paring Turner or Klinefelter samples to either male or
female samples. This was indeed the case for the vast
Fig. 4 Overlaps in affected loci between Turner and Klinefelter
samples. a Venn diagram showing the intersections between four
comparisons. The comparisons are abbreviated as T-M, T-F, K-M,
and K-F, where M male, F female, T Turner, K Klinefelter. Different
intersection groups are labeled from G1 to G15. Below each group
name the total number of genes is given as well as the number of
genes on the X chromosome (in parenthesis). b Relative direction
of methylation changes between the four different comparisons.
The X-linked (upper right) and autosomal (lower left) loci are shown
separately. The numbers in the Table correspond to the common
genes between the X- and the Y-axis categories. The red two-headed
arrows point to the gene numbers that switched orientation in their
methylation changes. Blue dashed boxes highlight the X-linked genes
that are hypomethylated in Klinefelter samples in comparison to
female samples, suggesting weaker X inactivation in Klinefelter than in
female samples
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male (T-M) and to female samples (T-F), we observed 336
autosomal genes were hypomethylated (in Turner samples),
while 63 genes were hypermethylated in comparison to
both genders (Fig. 4b, lower left; Additional file 4). Only 5
loci showed an opposite direction of methylation in com-
parison to both genders (indicated by red arrows in Fig. 4b).
In Klinefelter samples, the same situation was observedwith 17 loci which were hypomethylated compared to male
as well as female samples (K-M and K-F); 17 loci were
hypermethylated and only 2 loci showed an opposite direc-
tion of methylation compared to both genders. In contrast
to before, when comparing K-M to T-M and K-F to T-F, a
considerable amount of loci showed opposite directions of
methylation. Hence, some loci that were hypomethylated in
Turner samples compared to male samples are hyper-
methylated in Klinefelter samples and vice versa. Regarding
X-linked loci (Fig. 4b, upper right; Additional file 4), a
small number of loci (13 X-linked genes) are hypomethy-
lated in K-F and T-F, while at the same time hypermethy-
lated in K-M. This suggests a weaker inactivation at these
loci in Klinefelter individuals (indicated as blue dashed
box in Fig. 4b).
Gene ontology analysis matches the general clinical
profile of Turner and Klinefelter syndromes
Although we did not analyze the gene expression in this
study, we used the list of genes whose promoters showed
differences in methylation of more than 10 % to investi-
gate gene ontology enrichment. As this analysis will not
necessarily show the genes that are affected in term of
expression, it only shed more light on the function of
genes whose promoters are >10 % differentially methyl-
ated. To avoid any background interference of methyla-
tion changes due to X inactivation, only autosomal loci
were included in this study.
Turner samples showed a strong enrichment of
immune-related processes (Additional files 5 and 6). This
is true for the autosomal differentially methylated genes
when compared to male and female samples. Specifically,
the loci that differ between Turner and female samples in-
cluded immune system processes, immune response,
defense response to bacteria, cytokine production, and
meiosis. These enriched categories reveal a clear link to
the known relevant phenotype in Turner individuals, who
are prone to frequent middle ear and renal infections
[23–27]; furthermore, they are known to have higher rates
of autoimmune disorders [28] and to be generally infertile
[29]. In fact, the category meiosis contains fertility relevant
genes, such as DDX4 (DEAD (Asp-Glu-Ala-Asp) box
polypeptide 4), which is specifically expressed in female
germ cells [30], TRIP13 (Thyroid Hormone Receptor
Interactor 13), whose deficiency leads to loss of oocytes
around birth [31], and BRDT (Bromodomain testis-
specific protein), which is also expressed in mice oocytes
[32]. Similarity in scatterplots [33] of the enriched gene
ontology terms visualize unique categories and show that
the “immune”-related terms present the highest enrich-
ment with the lowest p values (Additional file 6: bigger
blue circles).
No highly significant enrichment was observed for dif-
ferentially methylated regions in Klinefelter samples
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small number of affected genes. Only two terms were
enriched when differentially methylated loci between
Klinefelter and female samples were analyzed: (1) piRNA
metabolic process and (2) positive regulation of kerati-
nocytes proliferation. The two enriched GO categories
against male samples were the following: (1) negative
regulation of hydrogen peroxide metabolic process and
(2) cellular process involved in reproduction in multicel-
lular organism. The latter is in line with the known infer-
tility associated with this syndrome. The respective GO
category contains eight genes, some of which have been
described to be directly involved in male infertility. For ex-
ample, PIWIL1 (piwi-like RNA-mediated gene silencing 1)
plays a central role in spermatogenesis and was found to
be differentially methylated in infertile patients [34], while
lack of SYCP1 (synaptonemal complex protein 1) in other-
wise healthy mice has been found to yield infertility [35].
Polymorphisms in MOV10L1 have been associated with
azoospermic male infertility [36]. MOV10L1 has been de-
scribed to play an important role in the protection of sper-
matocytes against retrotransposons by piwi-interacting
RNAs [37]. GAPDHS (glyceraldehyde-3-phosphate de-
hydrogenase, spermatogenic) is required for male mice fer-
tility and sperm motility [38]. SPACA1 deficient mice are
infertile and show abnormally shaped sperm heads [39].
Accurate pyrosequencing-based methylation measure-
ment at selected autosomal loci confirms the array data
In order to verify the array data with an alternative
method and a large number of samples, we selected sev-
eral loci based on the differential methylation data from
the 27K Illumina assay. Thus, we selected loci where only
Klinefelter (Fig. 5a) or Turner samples (Fig. 5b) were sig-
nificantly different compared to all others or where both
Turner and Klinefelter samples were significantly different
compared to male and female samples (Fig. 5c–d). For this
analysis, we used pyrosequencing assays on all available
samples from the four genotypes.
The results confirm the array data and clearly show
that all samples within one genotype tend to be affected.
At the same time, variability of methylation at most
studied loci even in the male and the female samples
was noted. Indeed, the range of methylation (in one
genotype) increases to 40 % at some loci, and only three
of the tested loci show relatively low variability (AMT
and SCRL). This is in agreement with the above observa-
tions that the affected loci tend to be in the intermediate
range of methylation and at weak or non-CpG islands,
which are characteristics of CpG sites of variable methy-
lation or CpG poor promoters [40].
While we did not include loci that show strong correl-
ation with age (as shown in Additional file 2) in the above
confirmation study, we nevertheless investigated thecorrelation between age and methylation for the loci stud-
ied by pyrosequencing (Additional file 7). We observed
several nominal correlations (p < 0.05), but only 3 out
(2 in males and 1 in Klinefelter) of 80 comparisons
remained significant after Bonferroni correction for mul-
tiple testing. Therefore, age is also not a major factor
influencing the methylation differences between the four
karyotype groups at the pyrosequencing-verified loci. The
individual loci-specific data was also used in hierarchical
cluster and PCA analysis, demonstrating the ability of
methylation markers to cluster different groups with per-
fect separation in one entity for Turner and male samples,
while Klinefelter and female samples appear to be closer
to each other (Additional file 8).
In order to investigate whether the methylation
changes induced by lack or addition of one X are coordi-
nated across the genome in a given individual, we stud-
ied the inter-loci correlations within every sample group,
if there is indeed a strong stimulus that induces the
methylation differences across all loci and if this stimu-
lus is acting equally than we would expect strong inter-
loci correlations in Turner and Klinefelter samples and
to a higher degree than those observed in male and fe-
male samples. However, no widespread strong correl-
ation was observed in any of the four groups (Additional
file 9), indicating that the observed variations in both
Turner and Klinefelter samples are not strongly coordi-
nated genome-wide. However, once a locus is affected,
the degree of variation could be stochastic in nature. Of
interest is the relatively higher frequency of negative cor-
relations between DIRA S3, HOXB6, and HOXA4 with
different loci in all groups, not just in Turner samples.
This is unexpected because HOXB6 and HOXA4 are
clearly hypermethylated (relative to male and female
samples) only in Turner samples, while other loci show
clear relative hypomethylation. The other groups did not
show such clear methylation differences, suggesting that
the observed changes in Turner samples display the
same basic intrinsic tendency found in other genotypes
but are somehow amplified by a still unknown mechan-
ism in the 45,X genome.
DNA methylation on the X chromosome reveals slightly
lower methylation levels in Klinefelter individuals relative
to females, significantly at the strongly inactivated loci,
while Turner individuals show hypomethylation, relative
to males at some PAR2 regions
As abnormal numbers of sex chromosomes have shown
a drift of methylation at autosomes, they might also in-
fluence the X chromosome inactivation status. There-
fore, we performed thorough methylation analysis of the
X chromosome by MeDIP followed by tilling array-
based methylation analysis covering about 10 Kb around
all promoter gene regions and all CpG islands including
Fig. 5 Detailed methylation data at selected loci in a large number of samples. The data at each locus, corresponding to 22 Turner (pink filled
circles), 28 male (blue triangles), 28 female (red inverted triangles), and 40 Klinefelter samples (sky blue diamonds), are represented as vertical scatter
plots with means (red horizontal bars) and standard deviation (grey horizontal bars). The black filled stars represent the samples used for the
pool of DNA in the methylation array experiments. a Hypomethylated loci in Klinefelter samples, b hypermethylated loci in Turner samples,
c hypomethylated in Turner and hypermethylated in Klinefelter samples, and d hypomethylated in Turner as well as Klinefelter samples.
The Illumina ID number is shown at the top of each plot followed by the genetic name of the loci that appear in parenthesis and then by the
p values of Kruskal-Wallis test for multiple group comparison; the p values of individual comparisons when significant are shown in grey
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27K), thus, enabling a study of global chromosomal
changes. Particularly, when we aligned all studied pro-
moter region in one sample to the transcription start
site on the X chromosomes, we observed that the sam-
ples with one X (male and Turner samples) show simi-
larly low methylation values, while the two sampleswith two X (female and Klinefelter samples) show rela-
tively higher methylation levels consistent with the ex-
pected X inactivation-associated methylation on the
inactive X chromosome (Fig. 6a). However, this analysis
also revealed a clear relative hypomethylation of Kline-
felter samples compared to female samples, suggesting
that methylation at the inactivated loci on the
Fig. 6 Trend in methylation differences at X chromosome between
46,XX and 47,XXY. a MeDIP data of the X chromosome in all four
groups; all data are aligned to the transcription start site (TSS): 7 kb
upstream and 3 kb downstream. b Illumina 27K methylation values;
the data are divided into 10 pins depending on the degree of X
inactivation of the corresponding locus (according to Carrel and
Willard [2]); average methylation at each pin is represented in the
plot and the significant p value between female and Klinefelter
samples at 0/9 is shown; all other comparisons between either
female and Klinefelter or between male and Turners were not
significant. c Detailed pyrosequencing data on two X-linked loci
(TEF3 and SLC35A2) showing the differences in average methylation
between female and Klinefelter samples
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female samples. This was further confirmed by the Illu-
mina data where the difference in methylation was clearly
more pronounced at the strongly inactivated regions
(Mann-Whitney test p = 0.0258; group 0/9 according to
Carrel and Willard [2]) and was not significant at either
the middle inactivated or the escapees (groups 1 to 9;
Fig. 6b). Furthermore, using the sensitive pyrosequenc-
ing method, we confirmed the existence of relative
hypomethylation in Klinefelter samples compared to
female samples at TEF3 (p = 0.0019), SLC35A2
(p = 0.0147) loci (Fig. 6c), and GJB1 (p = 0.0310)
(Fig. 7b).
The striking differences were more pronounced at the
PAR2 region. PARs were not covered by the 27K Illumina
array. However, several genes from PAR1 as well as PAR2
are covered by the MeDIP array analysis. The qualitative
MeDIP data show that, indeed, differences exist regarding
methylation status of X chromosomes, whereas mainly
Turner samples showed obvious differences at PAR2
(Fig. 7a). We next analyzed the four groups of samples
using pyrosequencing and, additionally, we included a
group of seven Turner samples with the 46,XX karyotype
(in the majority of cells) (the latter should undergo X in-
activation) and investigated the methylation status of two
loci at PAR2. The first analyzed locus was the SYBL1
(VAMP7) at PAR2 that showed a distinguishable pattern
of methylation. There was obvious methylation similar to
methylation at X-inactivated CpG sites (i.e., about 50 %
methylation) with the existence of two copies of the gene
(either X + X or X + Y), whereas nearly no methylation
was observed at 45,X Turner samples (Fig. 7b). Moreover,
even a gradual increase of methylation was observed from
46,XY to 46,XX to 47,XXY, suggesting that methylation
levels correlate with the copy numbers. This also agrees
with a report showing that SYBL1 (VAMP7) locus is inac-
tivated on both the inactive X chromosome and the Y
chromosome [41].
The 46,XX Turner samples were also as highly methyl-
ated as observed in female 46,XX samples (Fig. 7b). Inter-
estingly, this methylation trend at the PAR2 region was
not limited up to SYBL1 genes. We observed similar be-
havior for the CpG29 island that lies at the telomeric end
of PAR2. Therefore, based on the analysis of the selected
genes of PARs, we hypothesized that PAR2 regions display
unique behavior that distinguishes them from PAR1. Con-
trol regions (at non-PAR regions: GJB1 and XIST gene
body) subject to inactivation showed the expected methy-
lation levels consistent with the number of X chromo-
somes (Fig. 7b). As part of our ongoing effort regarding X
chromosomal abnormalities, we here provide DNA
methylation of selective PAR2 regions as an independent
assay for evaluation and close discrimination between un-
known clinical genotypes.Discussion
Turner and Klinefelter syndromes are caused by loss or
gain of one X chromosome (in the female and the male,
respectively) [42]. Little is known about the molecular































Fig. 7 Methylation at PAR regions. a MeDIP-based data. Lower panel shows the scatter plot with smooth curve fitted by Loess (without gaps).
Three different parts separately represent the PAR1, PAR2 and the non-PAR region. The upper panel highlights the raw MeDIP data as shown
by the SignalMap software for the loci that were also studied by pyrosequencing (shown in part B of the Figure). b Pyrosequencing at
two loci in PAR2: SYBL1 and CpG29. The p values of Kruskal-Wallis test for multiple group comparison are shown below the name of the
locus; the Mann-Whitney p values of individual comparisons when significant are shown in grey. In the middle of the figure, a diagram of
the X chromosome is displayed together with the transcripts and their level of expression (on a scale of 0 to 9 to the left of the figure).
T.S Turner syndrome
Sharma et al. Clinical Epigenetics  (2015) 7:76 Page 10 of 15the phenotype. In this study, we aimed to contribute to
the understanding of the molecular changes in these two
syndromes. Toward this end, we analyzed DNA methyla-
tion in whole blood samples from these two syndromes
as well as from healthy male and female individuals.
X chromosome numerical abnormalities affect
methylation on autosomes
We observed that methylation of mainly autosomal loci is
affected in both Turner and Klinefelter syndromes. Most
of them are found in the monosomic state of the X
chromosome (45,X). Differences at autosomal genes, such
the ones verified by pyrosequencing HOXA4, HOXB6,
DIRAS3, ZNF593, AMT, SCRL, TP53INP1, ITGB1BP1,
ENTPD1 TRPM2, and SEPTIN D1 (Fig. 5), clearly dem-
onstrate the impact of sex chromosomal abnormalities. In
case of the Turner phenotype, the hypermethylationstatus of HOXA4 and HOXB6 suggests a strong effect
on developmentally important genes. Apart from that,
genes involved in immune system processes, immune
and defense response to bacteria, cytokine production,
and meiosis were highly enriched in Turner samples
(Additional file 6). This clearly emphasizes the validity
of our findings because these are commonly expected
syndromes in Turner individuals.
It is known that blood lymphocytes are central in
adaptive immune responses. Thus, it not surprising that
we could identify methylation signature enriched with
major immune response factors from studying relevant
blood samples in Turner individuals. However, surprisingly,
we could also detect signatures of genes with altered
methylation levels that are functional in tissues, which are
developmentally far from blood like reproduction tissues/
organs. Possibly, changes in methylation arise systematically
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specific tissue. Confirming our findings are two studies that
performed genome-wide expression studies with Turner
cells [17, 18]. The differentially expressed genes from amni-
otic fluid RNA reveal enrichment of expression in
hematologic/immune cells [18], while from fibroblast, the
enrichments were associated with biological functions, such
as bone differentiation, glucose metabolism, and gonadal
developmental pathways [17]. However, when comparing
overlaps of autosomal differentially expressed loci from the
above studies and our list of differentially methylated loci,
only minor overlaps can be seen: SERPINB10 and LRRC17
(differentially expressed in fibroblast) [17] and LEP,
USP10, HPS4, SYNE2, PILRA, MST1, TRIP6, NPR2,
CLEC2D (differentially expressed in fibroblast) [18].
In analogy to Turner syndrome, Klinefelter samples only
harbored minimal methylation changes. The relatively
small number of affected loci was also observed by several
recent studies [11–14]. As none of these studies analyzed
methylation from whole blood, direct comparison to our
data is difficult. However, there was no overlap in the top
identified loci between all four studies, not even when we
compare the study of Huang et al. [13] and Zitmann et al.
[14], who both studied expression from the same tissue as
we did, i.e., whole blood. Moreover, even when we com-
pare our differential methylation data (autosomal loci in
whole blood) to the differential methylation data from
cerebellum and prefrontal cortex [11], we detected only
1/26 (OR2L13) and 2/23 (TTC15 and PIWIL1) overlaps, re-
spectively. This is not surprising, considering that (1) the
comparison made from the same two individual brain tis-
sues revealed only four overlaps (RIPK1, PTPRN2, C8orf71,
and SPAG1) and (2) no overlap was detected between dif-
ferentially expressed and differentially methylated loci.
These disappointing comparison results could be due to a
large inter-individual and/or inter-tissue variability that still
need to be addressed in larger studies.
Moreover, the absence of global correlation between
methylation and expression (in Turner and Klinefelter syn-
drome) are possibly due to the fact that the relatively small
methylation changes (what we observed mostly in the range
of 10–20 % of difference) represent a cellular memory;
whereby, the cell still retains slight differential methylation
at loci that were strongly differentially expressed during
earlier stages of embryonic development. Such a “memorial
epigenetic” signature was observed earlier in iPS cells de-
rived by factor-based reprogramming from different tissues
[43, 44]; as it was shown that methylation marks specific
for the original cells could still persist in the produced iPS.
Similar cases of methylation memory were reported for past
EBV infections [45], for past smoking [46] or even for past
pregnancy in mice mammary glands [47].
Meanwhile, the relatively small number of affected loci
in Klinefelter (compared to Turner) samples may be dueto very effective dosage compensation by inactivation of the
additional X. Yet the question remains as to why the mech-
anism of dosage compensation remains different or less ef-
fective in case of Monosomy X (Turner), although the
latter is the normal situation in males. The answer to this,
most probably, is the presence of Y chromosome in males,
which may harbor factor(s) that are needed for an appropri-
ate genome-wide epigenetic balance and/or provide regions
that pair with telomeric regions on the X (PAR1 and PAR2)
and thus modulate expressions [48, 49]. Therefore, the ex-
pression of PAR1 (2.6 Mb size, 29 genes) and PAR2 (320 kb
size, three genes) is modified on the X chromosome when
comparing Turner samples to both male and female sam-
ples. Indeed, our data provide indirect evidence for this sce-
nario since the methylation patterns of PAR2 differed
dramatically between 45,X and 46,XY (Fig. 7).
Klinefelter samples are significantly less methylated than
female samples on strongly silenced loci on the X
chromosome
The extra X chromosome in Klinefelter individuals
forces the cell not only to strictly apply the rule of X in-
activation, but also to face the interference of additional
genes that escape from inactivation on the additional
chromosome. Therefore, this female-like dosage com-
pensation in the presence of a Y chromosome may lead
to non-typical inactivation of the additional X in Kline-
felter samples. Indeed, we observed significantly lower
methylation on X loci than in female samples. Although
the statistical significance was limited to strongly si-
lenced genes (Fig. 6), the trend was observed even in
moderately (or incompletely) inactivated loci (2/9 till
6/9; Fig. 6b). This was also reported in a previous study,
which quantitatively determined methylation at few loci,
in 47,XXY and 46,XX groups [16]. The PGK1 strongly
inactivated locus (upon X chromosome inactivation)
showed statistically reduced methylation in the Klinefelter
groups (56 % methylated in comparison to 69 % in fe-
males), while FTHL17 that escapes the effect of inactiva-
tion still showed the tendency of being hypomethylated in
47,XXY (87 % methylated in comparison to 90 % in fe-
males). Furthermore, at the XIST locus, no statistical dif-
ferences between Klinefelter and female samples were
observed. However, a tendency to increased methylation
in the XIST 5′ region and gene body was observed in Kli-
nefelter samples (compared to female samples) in our
data. Therefore, we speculate that a slightly higher methy-
lation at promoter of XIST in Klinefelter individuals could
lower the efficiency of inactivation (Fig. 7).
Conclusions
In summary, our results reveal that X chromosome nu-
merical variations affect methylation at large numbers of
loci, mainly autosomal (Fig. 1). While specific DNA
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can largely distinguish Turner and Klinefelter samples
from female and male samples, respectively (Additional
file 8), they can also be used for detailed molecular ana-
lysis of differential patterns of DNA methylation and
epigenetic changes associated with aneuploidies (Fig. 2).
On autosomes, male, female, and Klinefelter samples ap-
pear to be more or less similar in their methylation pat-
terns, while Turner samples are distinguishably different
(Figs. 1 and 2). Nonetheless, Turner samples are still closer
to female than to male samples. Interestingly, methylation
patterns on PAR regions (Fig. 7) appear to differ between
male and Turner samples, and the inactivation of the
second X chromosome in Klinefelter appears to be less
effective than in females as could be inferred from the de-
creased methylation on the X-linked CpG sites (Fig. 6).
Our analysis is the first descriptive and comparative
study of the DNA methylation status of X chromosome ab-
normal phenotypes under the same experimental condi-
tions along with the comparison of healthy male (46,XY)
and healthy female samples (46,XX). With the presented
data it is possible to hypothesize that, although Klinefelter
(46,XXY) and female samples (46,XX) undergo the process
of X inactivation, the mechanism of X inactivation might
vary somewhat between female and Klinefelter samples.
Based on these data, we highlight the impact of X chromo-
somal aberrations on genome-wide methylation, which
could contribute to sex disparities and disease develop-
ment in Turner and Klinefelter syndrome individuals.
Methods
Patients, sample preparations, and ethics statement
Blood samples were collected from 25 Turner syndrome
patients: 18 samples with 45,X as revealed by conventional
haplotyping, while the remaining 7 samples consist of 2
with mosaic 45,X0/46,XX (80–95 % of peripheral blood
cells consist of 46,XX) and five with 46,XX with a variety
of structural abnormalities on the inactive X. All individ-
uals show the classic clinical Turner phenotype. All sam-
ples were obtained from the Pediatric Endocrinology
Division, University Children’s Hospital, Bonn, Germany.
Forty Klinefelter syndrome patients (expected karyotype
47,XXY) were recruited to this study through the German
Klinefelter Association, Falkenstein, Germany. In addition,
control blood samples, from 28 healthy men and 28
healthy women with normal X chromosome count, were
collected from blood donors at the Institute of Experi-
mental Hematology and Transfusion Medicine, Bonn,
Germany. All samples from all subjects were obtained
upon written informed consent. The study was approved
by the local ethics committee of the University Clinics of
Bonn (approval numbers 106/05 and 121/06). In addition
to conventional haplotyping, the X chromosome copy
number from the used blood samples in all individualswas confirmed by two copy number assay as previously
reported [50]. All samples were collected in Germany, and
all individuals are apparently of German origin with the
exception of two Turner and two Klinefelter individuals.
DNA methylation analysis
Methylated DNA immunoprecipitation (MeDIP) analysis
For the MeDIP experiments, DNA derived from three
individuals of the same karyotypes were equimolarilly
mixed to reduce the effect of inter-individual methyla-
tion differences and further used for fragmentations.
The samples used were chosen to be as close as possible
in their age and of German origin (in years, 11, 13, and
15 years old for Turners (45,X); 18, 18, and 19 years old
for males (46,XY); 18, 19, and 19 years old for females
(46,XX); 11, 15, and 16 years old for Klinefelters
(47,XXY)). DNA was fragmented by sonication (Branson
Sonifier B-12: output control to microTip limit, 35 times
at 5 s intervals); verification of the successful fragmenta-
tion in term of size and quantity was verified on 1 %
agarose gels. Immunoprecipitation of methylated DNA
in the fragmented DNA was done using the Methylated
DNA IP kit from Zymo Research (catalog number D5101)
according to the manufacturer’s instructions. To verify the
enrichment of the methylated portion of DNA after immu-
noprecipitation, several real time quantitative TaqMan-
based quantitative PCRs were used, namely CpG islands in
UBE 2B (non-methylated), C21orf93 (methylated), LDH-C
(methylated), and a no CpG control (data not shown). The
immunoprecipitated DNA as well as the input DNA were
further amplified using Sigma WGA2 kit. The amplified
product was submitted to NimbleGen DNA Methylation
Service, and the samples were hybridized to the 2.1 M Hu-
man Deluxe arrays that cover about 10 Kb of all promoters
(from 7250 bases upstream of each TSS to 3250 bases
downstream) and all CpG islands in hg18.
Illumina’s Infinium HumanMethylation27 array
The same DNA mixes used in the MeDIP experiments
were also processed with Illumina’s Infinium Human-
Methylation27 arrays. The bisulfite conversion of DNA
was done using Zymo Gold kit; the Illumina array pro-
cessing was performed according to standard protocols.
Each sample was done in duplicate.
Raw data (beta values) was extracted from Illumina Bead
Studio (version V2011.1). Methylation data was further
processed via the Bioconductor lumi package [51], which
works on M values rather than on beta values. The rela-
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normalization as further preprocessing steps imple-
mented in the lumi package. A detection p value cutoff
of 0.00001 was used to filter out signals below back-
ground, and only CpGs in autosomes were considered.
We used limma [53] to assess differential methylation of
CpG sites between patient groups. Cross reactive loci
were defined as described by Chen Y et al, [54]
Bisulfite pyrosequencing analysis
Genomic DNA (5 μg), extracted from blood of various ge-
notypes was bisulfite converted using the EZ 96-DNA
methylation kit (Zymo Research, Irvine, CA, USA) follow-
ing the manufacturer’s standard protocol. Pyrosequencing
assays were designed using the Pyromark Assay Design
Software (Qiagen, Germany). Bisulfite PCR amplification
was performed using Hot Star Taq DNA polymerase
(Qiagen, Germany) and optimized cycling conditions. Py-
rosequencing was performed using the Pyromark Q96
(Qiagen, Germany). A full list of bisulfite PCR and se-
quencing primers is given in Additional file 10.
Statistical analysis and data processing
Statistical analysis was done using the Prism software
(GraphPad Software Inc.) or the SAS software (SAS for
Windows, version 9.1; SAS Institute Inc., Cary, NC,
USA). Principle component analysis, heat maps, and
visualization of sample specific differences were done
using the Qlucore Omics Explorer version 2.3 (Qlucore
AB, Sweden). The MeDIP-array methylation data was
normalized and visualized using R software.
Gene ontology analysis
Gene ontology enrichment analysis was done using the
GOrilla server [55] and further visualization was done
using REVIGO visualization tool [33].
Additional files
Additional file 1: List of differentially methylated genes based on
the Illumina 27K data. The gene names in red are the loci studied by
pyrosequencing and presented in Fig. 5; the number in parenthesis
corresponds to the loci number in Fig. 5.
Additional file 2: Venn diagrams showing the overlaps between
differentially methylated CpGs and age sensitive DMRs. The overlaps
between differentially methylated regions from the four comparisons
(each Turner and Klinefelter with each male and female) with age
sensitive loci as determined by three studies. The list of Illumina ID cg
numbers are listed for each intersection and the percentage of loci
overlapping with age sensitive CpGs is given in red.
Additional file 3: List of genes in the groups of loci presented in
Fig. 4a representing intersections between different comparisons.
The gene names in red are the loci studied by pyrosequencing and
presented in Fig. 5, the number in parenthesis corresponds to the loci
number in Fig. 5.
Additional file 4: List of genes in the groups of loci presented in
Fig. 4b. The gene names in red are the loci studied by pyrosequencingand presented in Fig. 5, the number in parenthesis corresponds to the
loci number in Fig. 5.
Additional file 5: Summary of gene ontology anaylsis. Details with
functional ontology analysis of the differentially methylated loci in the
four comparisons: each of the Turner and the Klinefelter samples with
each of the male and the female samples.
Additional file 6: Functional gene ontology analysis in Turner
samples. Scatter plots representing all non-overlapping functional
categories are represented for both comparisons compared to male
(left) and female samples (right). Bubble color indicates the user-provided
p value (legend in upper right-hand corner) with the blue colored bubble
being the most significant; size indicates the frequency of the GO term in
the underlying GO database. X- and Y-axis represent two-dimensional
space derived by applying multidimensional scaling to a matrix of the
GO terms’ semantic similarities. The figures were generated with the
REVIGO online tool [33].
Additional file 7: Spearman Correlation between age and
pyrosequencing methylation results of individual loci. Each column
corresponds to one karyotype/group and each row corresponds to a
locus. p values and Rho values are represented as heat maps on the left
and write part respectively. The significances after Bonferroni correction
for multiple testing are labeled with a black square.
Additional file 8: Hierarchical clustering and PCA analysis of the
single loci methylation pyrosequencing data. A) The complete
data, non-supervised analysis; B) at a 5 % FDR that left six loci on
the list.
Additional file 9: Correlation analysis between methylation data
of individual loci studied by pyrosequencing, A) for individual
CpGs, B) for the average of one region. The loci included in this
analysis cover the ones from Fig. 5 for autosomal loci and Fig. 7 for
X-linked loci. Each of the four groups is represented in a separate heat
map, whereby the upper right triangle represents the correlation
p value and lower left triangle represent the Spearman Rho value. B, F
and M: significance in male and female samples (B), only in female
samples (F) and only in male samples (M); C: significance in healthy
male and female controls.
Additional file 10: List of primers. All primers used for PCR
amplifications and pyrosequencing.Competing interests
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